We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
ImmunityBio
IBRX
$7.44B
| $164K | ﹤0.01% |
62,028
+5,231
| +9% | +$14.1K |
|
3302
Arbutus Biopharma
ABUS
$865M
| $164K | ﹤0.01% |
52,938
-9,151
| -15% | -$30.4K |
|
|
CLDT
3303
Chatham Lodging
CLDT
$630M
| $164K | ﹤0.01% |
+23,468
| New | +$164K |
|
|
SCS
3304
DELISTED
Steelcase
SCS
| $163K | ﹤0.01% |
15,606
-1,620
| -9% | -$16.7K |
|
3305
FTAI Infrastructure
FIP
$500M
| $163K | ﹤0.01% |
26,357
-49,999
| -65% | -$253K |
|
3306
EVgo
EVGO
$200M
| $162K | ﹤0.01% |
44,353
+16,000
| +56% | +$54.8K |
|
3307
Atlas Energy Solutions
AESI
$1.49B
| $160K | ﹤0.01% |
11,992
-4,842
| -29% | -$66.1K |
|
3308
RLX Technology
RLX
$2.48B
| $160K | ﹤0.01% |
72,419
-4,759
| -6% | -$9.3K |
|
3309
Altimmune
ALT
$539M
| $159K | ﹤0.01% |
41,164
+9,558
| +30% | +$51.7K |
|
3310
Bain Capital Specialty
BCSF
$802M
| $159K | ﹤0.01% |
10,565
+390
| +4% | +$5.95K |
|
3311
Burford Capital
BUR
$907M
| $159K | ﹤0.01% |
11,137
-5,752
| -34% | -$75.2K |
|
3312
Mativ Holdings
MATV
$448M
| $159K | ﹤0.01% |
+23,268
| New | +$134K |
|
3313
PUT
Intuitive Surgical
ISRG
$121B
| $158K | ﹤0.01% |
9,500
-6,600
| -41% | -$3.45M |
|
3314
CareCloud
CCLD
$94.3M
| $157K | ﹤0.01% |
66,350
-3,741
| -5% | -$7.11K |
|
|
DHY
3315
Credit Suisse High Yield Credit Fund
DHY
$238M
| $156K | ﹤0.01% |
73,377
-17,418
| -19% | -$35.5K |
|
3316
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $156K | ﹤0.01% |
16,023
+11
| +0.1% | +$104 |
|
|
GNT
3317
GAMCO Natural Resources, Gold & Income Trust
GNT
$138M
| $155K | ﹤0.01% |
24,636
+52
| +0.2% | +$318 |
|
3318
Biohaven
BHVN
$2.16B
| $155K | ﹤0.01% |
10,972
-7,220
| -40% | -$129K |
|
|
UNIT
3319
Uniti Group
UNIT
$2.63B
| $155K | ﹤0.01% |
35,768
-15,176
| -30% | -$68.1K |
|
3320
Taboola.com
TBLA
$1.32B
| $154K | ﹤0.01% |
+42,161
| New | +$137K |
|
3321
Sunstone Hotel Investors
SHO
$2.19B
| $154K | ﹤0.01% |
+17,774
| New | +$153K |
|
|
UPB
3322
Upstream Bio Inc
UPB
$349M
| $154K | ﹤0.01% |
+14,030
| New | +$130K |
|
3323
Ameresco
AMRC
$1.15B
| $153K | ﹤0.01% |
+10,045
| New | +$131K |
|
3324
BlackRock Health Sciences Trust II
BMEZ
$957M
| $152K | ﹤0.01% |
10,694
-95
| -0.9% | -$1.36K |
|
3325
Planet Labs
PL
$7.3B
| $152K | ﹤0.01% |
24,938
+8,203
| +49% | +$33.5K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.